Pembrolizumab

Brand names: Keytruda

Pembrolizumab is an immune checkpoint inhibitor that helps the immune system fight cancer. It targets the PD-1 protein on immune cells, allowing them to recognize and attack cancer cells. It is approv

PD-1 Inhibitor (Immunotherapy)
Prescription Required
Ask Health.AI about Pembrolizumab
ON THIS PAGE
Table of Contents

At a Glance

What is it?
Pembrolizumab is an immune checkpoint inhibitor that helps the immune system fight cancer. It targets the PD-1 protein on immune cells, allowing them
Drug Class
PD-1 Inhibitor (Immunotherapy)

Overview

Pembrolizumab is an immune checkpoint inhibitor that helps the immune system fight cancer. It targets the PD-1 protein on immune cells, allowing them to recognize and attack cancer cells. It is approved for many cancer types including melanoma, lung cancer, and head and neck cancers.

Ask Health.AI about Pembrolizumab

Get instant answers from our AI health assistant

Hi! I can help answer your questions about Pembrolizumab. What would you like to know?

For informational purposes only. Always consult a healthcare professional.

Sources & References

  1. FDA Drug Label Information — fda.gov
  2. National Library of Medicine (DailyMed) — dailymed.nlm.nih.gov
  3. MedlinePlus Drug Information — medlineplus.gov
  4. American Pharmacists Association — pharmacist.com
  5. National Institutes of Health (NIH) — nih.gov
Was this helpful?